Eagle Pharmaceuticals, Inc. (EGRX)
NASDAQ: EGRX · IEX Real-Time Price · USD
4.610
-0.150 (-3.15%)
May 20, 2024, 4:30 PM EDT - Market closed

Eagle Pharmaceuticals Statistics

Total Valuation

EGRX has a market cap or net worth of $59.87 million. The enterprise value is $114.71 million.

Market Cap 59.87M
Enterprise Value 114.71M

Important Dates

The next estimated earnings date is Friday, May 31, 2024, before market open.

Earnings Date May 31, 2024
Ex-Dividend Date n/a

Share Statistics

EGRX has 12.99 million shares outstanding. The number of shares has increased by 2.48% in one year.

Shares Outstanding 12.99M
Shares Change (YoY) +2.48%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) 12.02%
Owned by Institutions (%) 79.36%
Float 9.00M

Valuation Ratios

The trailing PE ratio is 5.07 and the forward PE ratio is 1.16. EGRX's PEG ratio is 0.91.

PE Ratio 5.07
Forward PE 1.16
PS Ratio 0.23
Forward PS 0.24
PB Ratio 0.24
P/FCF Ratio n/a
PEG Ratio 0.91
Financial Ratio History

Enterprise Valuation

EV / Earnings 9.60
EV / Sales 0.45
EV / EBITDA 2.01
EV / EBIT 3.25
EV / FCF n/a

Financial Position

The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.28.

Current Ratio 2.16
Quick Ratio 1.51
Debt / Equity 0.28
Debt / EBITDA 1.23
Debt / FCF n/a
Interest Coverage 5.79

Financial Efficiency

Return on equity (ROE) is 5.00% and return on invested capital (ROIC) is 5.21%.

Return on Equity (ROE) 5.00%
Return on Assets (ROA) 3.00%
Return on Capital (ROIC) 5.21%
Revenue Per Employee $1.92M
Profits Per Employee $89,164
Employee Count 134
Asset Turnover 0.64
Inventory Turnover 1.55

Taxes

In the past 12 months, EGRX has paid $17.22 million in taxes.

Income Tax 17.22M
Effective Tax Rate 59.04%

Stock Price Statistics

The stock price has decreased by -78.38% in the last 52 weeks. The beta is 0.46, so EGRX's price volatility has been lower than the market average.

Beta (1Y) 0.46
52-Week Price Change -78.38%
50-Day Moving Average 4.87
200-Day Moving Average 9.06
Relative Strength Index (RSI) 48.65
Average Volume (30 Days) 135,474

Short Selling Information

The latest short interest is 1.20 million, so 9.26% of the outstanding shares have been sold short.

Short Interest 1.20M
Short Previous Month 1.18M
Short % of Shares Out 9.26%
Short % of Float 13.35%
Short Ratio (days to cover) 7.35

Income Statement

In the last 12 months, EGRX had revenue of $257.55 million and earned $11.95 million in profits. Earnings per share was $0.91.

Revenue 257.55M
Gross Profit 179.88M
Operating Income 41.01M
Pretax Income 29.17M
Net Income 11.95M
EBITDA 57.18M
EBIT 35.26M
Earnings Per Share (EPS) $0.91
Full Income Statement

Balance Sheet

The company has $15.35 million in cash and $70.19 million in debt, giving a net cash position of -$54.84 million or -$4.22 per share.

Cash & Cash Equivalents 15.35M
Total Debt 70.19M
Net Cash -54.84M
Net Cash Per Share -$4.22
Equity / Book Value 252.04M
Book Value Per Share 19.41
Working Capital 100.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.32 million and capital expenditures -$74,000, giving a free cash flow of -$9.39 million.

Operating Cash Flow -9.32M
Capital Expenditures -74,000
Free Cash Flow -9.39M
FCF Per Share -$0.72
Full Cash Flow Statement

Margins

Gross margin is 69.84%, with operating and profit margins of 15.92% and 4.64%.

Gross Margin 69.84%
Operating Margin 15.92%
Pretax Margin 11.33%
Profit Margin 4.64%
EBITDA Margin 22.20%
EBIT Margin 13.69%
FCF Margin -3.65%

Dividends & Yields

EGRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.48%
Shareholder Yield -2.48%
Earnings Yield 19.96%
FCF Yield -15.69%

Analyst Forecast

The average price target for EGRX is $17.00, which is 268.76% higher than the current price. The consensus rating is "Sell".

Price Target $17.00
Price Target Difference 268.76%
Analyst Consensus Sell
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

EGRX has an Altman Z-Score of 1.88 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.88
Piotroski F-Score 3